Taiwan: Utility model patents in Taiwan

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: Utility model patents in Taiwan

Filing a utility model application for an invention can be a quick way to obtain patent rights in Taiwan. A utility model application will mature into a registration with a duration of 10 years from the filing date as soon as the formality requirements are fulfilled. However, as a utility model application filed in Taiwan is not subject to a substantive examination looking at novelty and inventive step, before a utility model patent holder can enforce his right against an infringer, he needs to ask Taiwan's IP Office to produce a technical evaluation report in which prior art references are cited (if any) and the relevance of these to each claim is specified. The scope of the claims of a utility model patent might need to be restricted in light of the references cited by the IP Office.

According to current practice, a petition for amendment filed independently of an invalidation action is only subject to a formality examination. Taiwan's IP Office now adopts a different threshold from that of substantive examination. During a formality examination, the IP Office would generally consider a slight modification of the wording in the recitations of the claims to be a substantial change. This makes it quite difficult for the patent holder to obtain a favourable technical evaluation report when it comes to cited art.

Moreover, a utility model patent holder might need to submit a petition for claim amendment before the IP Office if he filed an infringement lawsuit and the accused infringer, in turn, filed a defence of patent invalidity as a countermeasure. In this case, the petition can be dismissed for failing the formality test even if the scope of the amended claims does not go beyond the originally filed claim or is narrower than the original claims.

To ensure the stability of utility model patent rights and to limit problems arising from filing claim amendments during a civil litigation procedure or application for a utility model technical evaluation report, both of which are subject to a formality examination, the IP Office is about to revise relevant regulations. It proposes prohibiting the filing of petitions for amendment of the claims of utility model patents in the absence of an invalidation action, an application for a technical evaluation report or a pending civil litigation case. Moreover, amendments to the claims of utility model patents shall be examined substantively. In the hope of establishing a sound claim amendment system for utility model patents, the IP Office is ready to revise patent law if a consensus can be reached at the forthcoming public hearings.

Yen-bin Gu


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

New platform, which covers SEPs covering the Wi-Fi 6 and Wi-Fi 7 standards, includes 10 patent owners
The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Gift this article